Non-Invasive Liver Disease Blood Test Hits the U.S. Market
Luxor Scientific and CIMA Sciences have launched OWLiver, a non-invasive blood test to detect all stages of metabolic liver disease.
Read MorePosted by Chris Wolski | May 16, 2024 | Diabetes & Metabolic Diseases |
Luxor Scientific and CIMA Sciences have launched OWLiver, a non-invasive blood test to detect all stages of metabolic liver disease.
Read MorePosted by Andy Lundin | Mar 21, 2024 | Gastrointestinal Infections |
Lucid Diagnostics announced that a prospective VA screening study demonstrated strong performance of its EsoGuard Esophageal DNA test.
Read MorePosted by Andy Lundin | Jan 12, 2024 | Unknown Origin & Other Cancer Types |
Individuals with obesity are more likely to have MGUS, a benign blood condition that often precedes multiple myeloma.
Read MorePosted by Andy Lundin | Jan 2, 2024 | Diabetes & Metabolic Diseases, Womens Health |
A new study evaluated the diagnostic value of certain markers before or at the time of screening for gestational diabetes mellitus.
Read MorePosted by Andy Lundin | Dec 5, 2023 | Cancer |
UCLA Researchers received $9.1 million in grant funding from the National Cancer Institute to advance liquid biopsy tech for cancer detection.
Read More